Clinical Trial Update: Telotristat Etiprate for Carcinoid Syndrome Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Telotristat Etiprate for carcinoid syndrome has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Syndrome

Drugs mentioned

• Telotristat Etiprate (telotristat etiprate)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Carcinoid Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2017-09-25